These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2428794

  • 1. Protection by WR-2721 of human bone marrow function following irradiation.
    Constine LS, Zagars G, Rubin P, Kligerman M.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1505-8. PubMed ID: 2428794
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase I controlled trials of WR-2721 and cyclophosphamide.
    Glick JH, Glover D, Weiler C, Norfleet L, Yuhas J, Kligerman MM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1777-80. PubMed ID: 6090370
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Toxicity and radiation protective effect of WR-77913 in BALB/c mice.
    Mendiondo OA, Connor AM, Grigsby P.
    Acta Radiol Oncol; 1982 Sep; 21(5):319-23. PubMed ID: 6297251
    [Abstract] [Full Text] [Related]

  • 9. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA, Connor AM, Grigsby P.
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(3-4):553-5. PubMed ID: 6286552
    [Abstract] [Full Text] [Related]

  • 10. Phase I trials of WR-2721 and cis-platinum.
    Glover D, Glick JH, Weiler C, Yuhas J, Kligerman MM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1781-4. PubMed ID: 6090371
    [Abstract] [Full Text] [Related]

  • 11. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
    Murray D, Altschuler EM, Hunter N, Milas L.
    Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
    McChesney SL, Gillette EL, Dewhirst MW, Withrow SJ.
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
    [Abstract] [Full Text] [Related]

  • 14. Drug combination against single drug treatment in radiation protection of the bone marrow CFU.
    Bisht KS, Uma Devi P, Jagetia GC, Kamath G.
    Strahlenther Onkol; 1990 Aug; 166(8):545-8. PubMed ID: 2168583
    [Abstract] [Full Text] [Related]

  • 15. A phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies.
    Coia L, Krigel R, Hanks G, Comis R, Algazy K, Peters R, McCulloch W, Schien P.
    Int J Radiat Oncol Biol Phys; 1992 Aug; 22(4):791-4. PubMed ID: 1312076
    [Abstract] [Full Text] [Related]

  • 16. Protection of mouse lung by WR-2721 after fractionated doses of irradiation.
    Travis EL, De Luca AM.
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):521-6. PubMed ID: 2982773
    [Abstract] [Full Text] [Related]

  • 17. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS, Nelson NJ, Mahler P, Anderson K, Krohn KA, Menard T.
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [Abstract] [Full Text] [Related]

  • 18. Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection.
    Spence AM, Krohn KA, Edmondson SW, Steele JE, Rasey JS.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1479-82. PubMed ID: 3019963
    [Abstract] [Full Text] [Related]

  • 19. WR-2721 as cytotoxic and radioprotective agent in treatment of murine lymphoma with total body irradiation.
    Coia LR, Brown DQ, Hardiman J.
    NCI Monogr; 1988 Aug; (6):235-9. PubMed ID: 2832762
    [Abstract] [Full Text] [Related]

  • 20. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.
    Poulter CA, Cosmatos D, Rubin P, Urtasun R, Cooper JS, Kuske RR, Hornback N, Coughlin C, Weigensberg I, Rotman M.
    Int J Radiat Oncol Biol Phys; 1992 Aug; 23(1):207-14. PubMed ID: 1374061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.